The role of prebiotics and synbiotics in critically ill patients - PubMed (original) (raw)
Review
The role of prebiotics and synbiotics in critically ill patients
William Manzanares et al. Curr Opin Clin Nutr Metab Care. 2008 Nov.
Abstract
Purpose of review: To examine current knowledge regarding the role of prebiotics in critical illness when administered singly or in combinations with probiotics (synbiotics).
Recent findings: Recent experimental and clinical studies support the fact that bioecological intestinal control with early enteral nutrition enriched with synbiotics may reduce systemic inflammation, improve the immunological status of the intestinal mucosa and help prevent infections in critically ill patients. Three prebiotics, oligofructose, galactooligosaccharides and lactulose are able to modify the balance of intestinal microbiota. It appears that treatment with synbiotics during critical illness should restore the balance of microbial communities in a beneficial way with positive effects on intestinal permeability and bacterial translocation. Only data from small trials are currently available to support use of prebiotics and synbiotics in the treatment of different clinical scenarios. However, in some critical conditions, this supplementation has so far not been effective.
Summary: Numerous questions about the molecular mechanisms of action or clinical indications of prebiotics remain unanswered. Large, randomized, multicentre trials are necessary to precisely define the role of prebiotics as therapeutic agents in critical illness. These trials must identify clinically significant improvements in relevant clinical endpoints before any large-scale usage is advocated for critical illness.
Similar articles
- Probiotics, prebiotics, and synbiotics.
de Vrese M, Schrezenmeir J. de Vrese M, et al. Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Adv Biochem Eng Biotechnol. 2008. PMID: 18461293 Review. - Prebiotic effects: metabolic and health benefits.
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Roberfroid M, et al. Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Br J Nutr. 2010. PMID: 20920376 Review. - Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions.
Gourbeyre P, Denery S, Bodinier M. Gourbeyre P, et al. J Leukoc Biol. 2011 May;89(5):685-95. doi: 10.1189/jlb.1109753. Epub 2011 Jan 13. J Leukoc Biol. 2011. PMID: 21233408 Review. - Prebiotics and synbiotics: concepts and nutritional properties.
Roberfroid MB. Roberfroid MB. Br J Nutr. 1998 Oct;80(4):S197-202. Br J Nutr. 1998. PMID: 9924284 Review. - Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence.
Frei R, Akdis M, O'Mahony L. Frei R, et al. Curr Opin Gastroenterol. 2015 Mar;31(2):153-8. doi: 10.1097/MOG.0000000000000151. Curr Opin Gastroenterol. 2015. PMID: 25594887 Review.
Cited by
- Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit.
Choy A, Freedberg DE. Choy A, et al. Therap Adv Gastroenterol. 2020 Jul 17;13:1756284820939447. doi: 10.1177/1756284820939447. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32733601 Free PMC article. Review. - Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S, Goto Y, Miyake H, Nagai H, Yoshioka Y, Yuasa N, Takamizawa J. Tsuruta S, et al. Support Care Cancer. 2020 Jun;28(6):2761-2768. doi: 10.1007/s00520-019-05122-3. Epub 2019 Nov 14. Support Care Cancer. 2020. PMID: 31724073 - Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.
Venegas-Borsellino C, Kwon M. Venegas-Borsellino C, et al. Curr Nutr Rep. 2019 Dec;8(4):347-355. doi: 10.1007/s13668-019-00299-9. Curr Nutr Rep. 2019. PMID: 31701433 Review. - Probiotics in critically ill patients.
Moradi Moghaddam O. Moradi Moghaddam O. Anesth Pain Med. 2011 Fall;1(2):58-60. doi: 10.5812/kowsar.22287523.2291. Epub 2011 Sep 26. Anesth Pain Med. 2011. PMID: 25729656 Free PMC article. No abstract available. - Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients.
Janka V, Ladislav K, Jozef F, Ladislav V. Janka V, et al. Wien Klin Wochenschr. 2013 Jun;125(11-12):316-25. doi: 10.1007/s00508-013-0371-x. Epub 2013 May 4. Wien Klin Wochenschr. 2013. PMID: 23644928
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials